CAMBRIDGE, Mass.--(BUSINESS WIRE)--June 8, 2006--Altus Pharmaceuticals Inc. (Nasdaq: ALTU - News), a biopharmaceutical company developing and commercializing oral and injectable protein therapeutics for patients with gastrointestinal and metabolic disorders, announced today that Burkhard Blank, M.D. has been appointed Senior Vice President Medicine, Regulatory Affairs and Project Management. In this role, Dr. Blank will be responsible for clinical development, medical affairs, regulatory affairs and quality assurance as well as project management.
